AVEO Announces Exclusive Worldwide License Agreement for, Development, Commercialization of AV-380 and Related Antibodies
August 17, 2015 at 06:02 AM EDT
AVEO Oncology (NASDAQ: AVEO) today announced an exclusive, worldwide license agreement with Novartis for the development ...
